A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients

This study is currently recruiting participants.
Verified June 2012 by Access Pharmaceuticals, Inc.
Sponsor:
Information provided by (Responsible Party):
Access Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01283906
First received: January 25, 2011
Last updated: June 20, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2012
  Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)